MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

REGENXBIO (RGNX) Ownership - Who owns REGENXBIO?

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
371
Web
https://www.regenxbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
316.65M
P/E Ratio
N/A
Total Cash
150.49M
Projected Growth
N/A
Total Debt
71.07M
Revenue
87.82M
Risk (Beta)
1.96
Dividend Yield
N/A
Total Cash/Share
2.91
Total Debt/Equity
N/A
Revenue/Share
1.69 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RGNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RGNX
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
371
Web
https://www.regenxbio.com